Predictors of persistent pain after breast cancer surgery: A systematic review and meta-analysis of observational studies

CMAJ

Volumn 188, Issue 14, 2016, Pages E352-E361

  Wang, Li ^a,b,d   Guyatt, Gordon H ^b   Kennedy, Sean A ^e   Romerosa, Beatriz ^g   Kwon, Henry Y ^h   Kaushal, Alka ^b   Chang, Yaping ^b   Craigie, Samantha ^a   De Almeida, Carlos P B ⁱ   Couban, Rachel J ^a   Parascandalo, Shawn R ^j   Izhar, Zain ^b,c   Reid, Susan ^b   Khan, James S ^f   McGillion, Michael ^b   Busse, Jason W ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d SICHUAN UNIVERSITY   (China)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g Hospital Univ de Toledo   (Spain)

^h WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^j UNIVERSITY COLLEGE CORK   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; AXILLARY LYMPH NODE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; HUMAN; LYMPH NODE DISSECTION; META ANALYSIS; POSTOPERATIVE PAIN; RISK FACTOR; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; AXILLA; BREAST NEOPLASMS; CHRONIC PAIN; FEMALE; MASTECTOMY; MASTODYNIA; OBSERVATIONAL STUDY; ODDS RATIO; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PARTIAL MASTECTOMY; PREOPERATIVE PERIOD; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHRONIC PAIN; FEMALE; HUMANS; LYMPH NODE EXCISION; MASTECTOMY; MASTECTOMY, SEGMENTAL; MASTODYNIA; OBSERVATIONAL STUDIES AS TOPIC; ODDS RATIO; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PREOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; RISK FACTORS;

EID: 84990042020     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.151276     Document Type: Article

References (72)

1. Canadian cancer statistics 2014. Toronto: Canadian Cancer Society; 2014. Available: www.cancer.ca/~/media/cancer.ca/ CW/cancer%20information/cancer%20101/Canadian%20cancer %20statistics/Canadian-Cancer-Statistics-2014-EN.pdf?la=en (accessed 2015 July 20).
2. Breast cancer facts and fgures 2013-2014. Atlanta: American Cancer Society; 2013. Available: www.cancer.org/acs/groups/content/ @research/documents/document/acspc-042725.pdf (accessed 2015 July 20).
3. Jung BF, Ahrendt GM, Oaklander AL, et al. Neuropathic pain following breast cancer surgery: proposed classifcation and research update. Pain 2003;104:1-13.
4. Kehlet H, Jensen Troels S, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618-25.
5. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain 2011;12:725-46.
6. Brummett CM. Chronic pain following breast surgery. Tech Reg Anesth Pain Manage 2011;15:124-32.
7. Smith HS, Wu SX. Persistent pain after breast cancer treatment. Ann Palliat Med 2012;1:182-94.
8. Cregg R, Anwar S, Farquhar-Smith P. Persistent postsurgical pain. Curr Opin Support Palliat Care 2013;7:144-52.
9. Haroutiunian S, Nikolajsen L, Finnerup NB, et al. The neuropathic component in persistent postsurgical pain: a systematic literature review. Pain 2013;154:95-102.
10. Hidding JT, Beurskens CH, van der Wees PJ, et al. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One 2014;9:e96748.
11. Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 2009;16:1959-72.
12. Liu CQ, Guo Y, Shi JY, et al. Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer 2009;45: 1560-8.
13. Lee TS, Kilbreath SL, Refshauge KM, et al. Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 2008;110:19-37.
14. Levangie PK, Drouin J. Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat 2009;116:1-15.
15. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
16. Macrae WA, Davies HTO. Chronic postsurgical pain. In: Crom-bie IL, Linton S, Croft P, et al., editors. Epidemiology of pain. Seattle: IASP Press; 1999:125-42.
17. Randolph AG, Cook D, Guyatt G. Prognosis. In: Guyatt G, Ren-nie D, Meade M, et al., editors. Users' guides to the medical literature: a manual for evidence-based clinical practice. 3rd ed. New York: McGraw-Hill; 2015:421-9.
18. Tendal B, Nuesch E, Higgins JP, et al. Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study. BMJ 2011;343:d4829.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
20. Thorlund K, Walter SD, Johnston BC, et al. Pooling health-related quality of life outcomes in meta-analysis - a tutorial and review of methods for enhancing interpretability. Res Synth Methods 2011;2:188-203.
21. Bucher HC, Guyatt GH, Griffth LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997;50:683-91.
22. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. London (UK): The Cochrane Collaboration; 2011. Available: www.cochrane -handbook.org (accessed 2015 July 20).
23. Wang Z. Converting odds ratio to relative risk in cohort studies with partial data information. J Stat Softw 2013;55:1-12.
24. Murad MH, Montori VM, Ioannidis JPA, et al. Fixed-effects and random-effects models. In: Guyatt G, Rennie D, Meade M, et al., editors. Users' guides to the medical literature: a manual for evidence-based clinical practice. 3rd ed. New York: McGraw-Hill; 2015:507-14.
25. Gelman A, Hill J. Missing-data imputation. In: Gelman A, Hill J, editors. Data analysis using regression and multilevel/hierarchical models. New York: Cambridge University Press; 2006:529-44.
26. Mejdahl MK, Andersen KG, Gartner R, et al. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ 2013;346:f1865.
27. Iorio A, Spencer FA, Falavigna M, et al. Use of GRADE for assessment of evidence about prognosis: rating confdence in estimates of event rates in broad categories of patients. BMJ 2015;350:h870.
28. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
29. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-anal-ysis detected by a simple, graphical test. BMJ 1997;315:629-34.
30. Rücker G, Schwarzer G, Carpenter JR, et al. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 2008;8:79.
31. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
32. Alves Nogueira Fabro E, Bergmann A, do Amaral E Silva B, et al. Post-mastectomy pain syndrome: incidence and risks. Breast 2012;21:321-5.
33. Andersen KG, Jensen MB, Kehlet H, et al. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fuorouracil compared with docetaxel + epirubicin and cyclophosphamide. Acta Oncol 2012;51:1036-44.
34. Bantema-Joppe EJ, Schilstra C, de Bock GH, et al. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up. Int J Radiat Oncol Biol Phys 2012;83: e471-7.
35. Bruce J, Thornton AJ, Powell R, et al. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain 2014; 155:232-3.
36. Caffo O, Amichetti M, Ferro A, et al. Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat 2003; 80:39-48.
37. De Oliveira GS Jr, Chang R, Khan SA, et al. Factors associated with the development of chronic pain after surgery for breast cancer: a prospective cohort from a tertiary center in the United States. Breast J 2014;20:9-14.
38. De Oliveira GS Jr, Bialek JM, Nicosia L, et al. Lack of association between breast reconstructive surgery and the development of chronic pain after mastectomy: a propensity matched retrospective cohort analysis. Breast 2014;23:329-33.
39. Hack TF, Kwan WB, Thomas-MacLean RL, et al. Predictors of arm morbidity following breast cancer surgery. Psychooncology 2010;19:1205-12.
40. Husen M, Paaschburg B, Flyger HL. Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 2006;15:620-8.
41. Lundstedt D, Gustafsson M, Steineck G, et al. Risk factors of developing long-lasting breast pain after breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 2012;83:71-8.
42. Poleshuck EL, Katz J, Andrus CH, et al. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 2006;7:626-34.
43. Rief W, Bardwell WA, Dimsdale JE, et al. Long-term course of pain in breast cancer survivors: a 4-year longitudinal study. Breast Cancer Res Treat 2011;130:579-86.
44. Steegers MA, Wolters B, Evers AW, et al. Effect of axillary lymph node dissection on prevalence and intensity of chronic and phantom pain after breast cancer surgery. J Pain 2008; 9:813-22.
45. Swenson KK, Nissen MJ, Ceronsky C, et al. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002;9:745-53.
46. Tasmuth T, Kataja M, Blomqvist C, et al. Treatment-related factors predisposing to chronic pain in patients with breast cancer - a multivariate approach. Acta Oncol 1997;36:625-30.
47. Ververs JMMA, Roumen RMH, Vingerhoets AJJM, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001;37:991-9.
48. Warmuth MA, Bowen G, Prosnitz LR, et al. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 1998;83:1362-8.
49. Wilson GC, Quillin RC 3rd, Hanseman DJ, et al. Incidence and predictors of neuropathic pain following breast surgery. Ann Surg Oncol 2013;20:3330-4.
50. Winters ZE, Haviland J, Balta V, et al. Integration of patient-reported outcome measures with key clinical outcomes after immediate latissimus dorsi breast reconstruction and adjuvant treatment. Br J Surg 2013;100:240-51.
51. Yang EJ, Park WB, Seo KS, et al. Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol 2010;101:84-91.
52. Johansen S, Fossa K, Nesvold IL, et al. Arm and shoulder morbidity following surgery and radiotherapy for breast cancer. Acta Oncol 2014;53:521-9.
53. Tian Y, Schofeld PE, Gough K, et al. Profle and predictors of long-term morbidity in breast cancer survivors. Ann Surg Oncol 2013;20:3453-60.
54. Hofsø K, Rustøen T, Cooper BA, et al. Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer. J Pain Symptom Manage 2013;45:980-1006.
55. Roth RS, Lowery JC, Davis J, et al. Preoperative affective distress and somatic complaints predict persistent pain after post-mastectomy breast reconstruction. Eur J Plast Surg 2007; 29:227-33.
56. Waters EA, Liu Y, Schootman M, et al. Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients. Ann Behav Med 2013;45:57-68.
57. Couceiro TC, Valença MM, Raposo MC, et al. Prevalence of post-mastectomy pain syndrome and associated risk factors: a cross-sectional cohort study. Pain Manag Nurs 2014;15:731-7.
58. Meretoja TJ, Leidenius MHK, Tasmuth T, et al. Pain at 12 months after surgery for breast cancer. JAMA 2014;311:90-2.
59. Bell RJ, Robinson PJ, Nazeem F, et al. Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv 2014;8:1-8.
60. Shahbazi R, Akbari ME, Hashemian M, et al. High body mass index and young age are not associated with post-mastectomy pain syndrome in breast cancer survivors: a case-control study. Iran J Cancer Prev 2015;8:29-35.
61. Boman L, Bjorvell H, Langius A, et al. Two models of care as evaluated by a group of women operated on for breast cancer with regard to their perceived well-being. Eur J Cancer Care (Engl) 1999;8:87-96.
62. Gerbershagen HJ, Rothaug J, Kalkman CJ, et al. Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. Br J Anaesth 2011;107:619-26.
63. Chaparro LE, Smith SA, Moore RA, et al. Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev 2013;7:CD008307.
64. Mishriky BM, Waldron NH, Habib AS. Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis. Br J Anaesth 2015;114:10-31.
65. Bland KI, Scott-Conner CE, Menck H, et al. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 1999;188:586-95.
66. Mansel RE, Fallowfeld L, Kissin M, et al. Randomized multi-center trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609.
67. Kostanyan M. Intercostobrachial syndrome after nerve-sparing axillary lymph node dissection. Eur J Cancer 2014;50:S127.
68. Zhu JJ, Liu XF, Zhang PL, et al. Anatomical information for intercostobrachial nerve preservation in axillary lymph node dissection for breast cancer. Genet Mol Res 2014;13:9315-23.
69. Abdullah TI, Iddon J, Barr L, et al. Prospective randomized controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer. Br J Surg 1998;85:1443-5.
70. Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2014;32:1365-83.
71. Blanchard DK, Donohue JH, Reynolds C, et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138:482-7, discussion 487-8.
72. Andreae MH, Andreae DA. Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis. Br J Anaesth 2013;111:711-20.